ICU patients are identifi ed as targets for quality of care and patient safety improvement strategies. Critically ill patients are at high risk for complications due to the complex and invasive nature of critical care treatments and procedures, the severity of their medical conditions, and the use of immunosuppressive drugs. Healthcareassociated infections are the most common complications aff ecting hospitalized patients and are associated with signifi cant morbidity and mortality [1,2]; they account for approximately 100,000 deaths yearly in the United States [3] . Currently, infection control is a critical element of patient care and many healthcare-associated infection episodes are considered potentially preventable. Th e idea that 'most infections are un avoidable and some could be preventable' has been changed to 'all infections are potentially preventable unless proven otherwise' [4, 5] . However, it is clear that although valid data on the proportion of unpreventable episodes in diff erent ICU settings are not available, diff erent types of infection, such as catheter-associated bloodstream infections and healthcare-associated pneu monia, are preventable through diff erent strategies but also with unequal results [5] .
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Several strategies have proven effi cacy for preventing central line-associated blood stream infections (CLABSIs), but care bundle approaches seem to be the most prominent. Prevention strategies based on care bundles aim to translate the best available evidence into clinical practice, by allowing for a more uniform management of the patient. By comparison, implementation of individual interventions might improve patient care, but the implementation of several simple measures simul taneously, as a bundle, has a greater likelihood of improving outcome.
Exline and colleagues [6] implemented a systematic team approach with very aggressive interventions surrounding the Institute for Healthcare Improvement (IHI) CLA-BSI bundle focusing on continuous improvement of the strategy. In addition to the care bundle implementation, improvements in surveillance, review of the intevention process, timely feedback on CLA-BSI occurrence and sentinel event investigation of CLA-BSI at the unit level, positive reinforcement strategies, improve ments in clinical and molecular epidemiological surveillance, educational strategies and clorhexidine baths were also implemented. Th e positive results are encouraging and show the importance of continuous improvement of processes and surveillance with appropriate feedback as factors leading to quality improvement and better results. Interesting fi ndings also include concerns regarding professional turnover and environmental issues. An additional insight provided by the study concerns the number of lumens and the very defi nition we use for surveillance purposes. As the denominator in the rate includes days of catheter use by patients, not considering the number of lumens or lines the patient is using, and with the increased complexity Abstract ICU patients are identifi ed as targets for quality of care and patient safety improvement strategies. Critically ill patients are at high risk for complications due to the complex and invasive nature of critical care. Several reports in the literature describe initiatives aiming to zero the healthcare-associated infection rate. We discuss the results of a study assessing a systematic team approach with very aggressive interventions surrounding the Institute for Healthcare Improvement Central Line-associated Blood Stream Infection bundle, which obtained a successful reduction of the rates. In addition, we discuss why some healthcare-associated infections are not fully preventable and the diff erent reasons for this, the identifi cation of which would be a cornerstone of quality improvement and safety promotion initiatives in critically ill patients. involved in treating ICU patients, many times using fi ve or six lines, the eff ect of prevention strategies might be underestimated. Th is may argue for counting the number of lines or even lumens for a lumen/patient/day count, despite limitations and feasibility issues in many settings.
However, as acknowledged by the authors, although care bundle implementation appears to be associated with successful reduction of some healthcare-associated infection rates, these may not always be preventable given the high sensitivity and low specifi city of clinical defi nitions and because some of the cultures with signifi cant pathogens may be related to contamination or catheter colonization. Th erefore, there should be a cautious interpretation of the impact of reduction and zero healthcare-associated infection policies that are benefi cial in other clinical syndromes. Several diff erences regarding pathophysiology should be considered and generalization of the fi ndings should be made cautiously. Considering healthcare-associated pneumonia, for example, misinterpretation of prevention study results and the pathophysiology of ventilator-associated pneumonia (VAP) may lead to an erroneous idea that a 'zero-VAP rate' is feasible. While CLA-BSIs are associated primarily with inaccuracies in insertion technique and handling of the catheter, healthcare-associated pneumonia pathophysiology is mainly determined by endogenous aspects, including endogenous fl ora and risk factors. Although some VAP care bundle study results are encouraging for obtaining an important reduction in VAP episodes, pathophysiological aspects of VAP, such as diff erences between early and late VAP episode risk factors that diff er between trauma and medical patients, limit their ability to prevent all episodes of VAP [5] . Klompas [7] recently reported initiatives that misleadingly lower VAP rates, including interpretation of clinical signs and chest X-ray as strictly as possible, require consensus between preventionists and intensivists, or require microbiological documentation to confi rm VAP diagnosis. Th is makes evident the high variability and how artifi cial or manipulated the rates might be.
An approach similar to that described for CLA-BSI is described in the FADO project [8] , a strategy to assess the impact of implementing a care bundle package for VAP prevention on VAP rates and duration of mechanical ventilation. Th is original study evaluated an intervention based on a care bundle concept to prevent VAP, with interventions based on the pathophysiology of VAP, slightly diff erent form those reported in IHI VAP bundle studies, and obtained a reduction in the incidence risk ratio of VAP of 0.78 (95% confi dence interval 0.15 to 0.99), median ICU length of stay (from 10 to 6 days) and duration of mechanical ventilation (from 8 to 4 days) for patients with full bundle compliance (intervention period).
Th e prevention of healthcare-associated infections should be a cornerstone for quality improvement and safety promotion initiatives in critically ill patients. Signifi cant improvements in outcomes can be achieved with high compliance in implementing a care bundle package for prevention of healthcare-associated infections. In addition, although it is diffi cult to maintain over a longterm period, signifi cant benefi ts were documented by Exline and colleagues [6] , and several strategies might be implemented to improve compliance with and the effi cacy of these approaches. Eff ective design and implemen tation require a multidisciplinary approach taking into account barriers as well as facilitators. However, during the path towards a zero rate, we should not overlook that although the healthcare-associated infection concept makes epidemiological sense, the pathophysiology of the diff erent clinical syndromes is variable, as is their potential to be fully preventable. So undertaking the journey towards a zero rate is valid but we should acknowledge that many diff erent paths are needed to accommodate the complexity of the concept we are dealing with.
